Can we predict the failure of electrical cardioversion of acute atrial fibrillation? the FinCV study

PACE - Pacing and Clinical Electrophysiology

Volumn 38, Issue 3, 2015, Pages 368-375

  Grönberg, Toni ^a   Hartikainen, Juha E K ^b   Nuotio, Ilpo ^a   Biancari, Fausto ^c   Vasankari, Tuija ^a   Nikkinen, Marko ^b   Ylitalo, Antti ^d   Airaksinen, K E Juhani ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d SATAKUNTA CENTRAL HOSPITAL   (Finland)

Author keywords

antiarrhythmic drug therapy; atrial fibrillation; cardioversion; clinical recurrence; failure rate

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; DISOPYRAMIDE; DRONEDARONE; FLECAINIDE; PROPAFENONE; QUINIDINE;

ADULT; AGE; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; DISEASE DURATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY (TOPIC); RECURRENCE RISK; SINUS RHYTHM; TREATMENT DURATION; TREATMENT OUTCOME; ACUTE DISEASE; ADOLESCENT; ATRIAL FIBRILLATION; CLINICAL TRIAL; FINLAND; HEART PACING; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT FAILURE; VERY ELDERLY;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; ELECTRIC COUNTERSHOCK; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 84924020735     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12561     Document Type: Article

References (24)

1. Kuppahally SS, Foster E, Shoor S, Steimle AE,. Short-term and long-term success of electrical cardioversion in atrial fibrillation in managed care system. Int Arch Med 2009; 2: 39.
2. Toso E, Blandino A, Sardi D, Battaglia A, Garberoglio L, Miceli S, Azzarro G, et al. Electrical cardioversion of persistent atrial fibrillation: Acute and long-term results stratified according to arrhythmia duration. Pacing Clin Electrophysiol 2012; 35: 1126-1134.
3. Scheuermeyer F, Grafstein E, Stenstrom R, Innes G, Poureslami I, Sighary M,. Thirty-day outcomes of emergency department patients undergoing electrical cardioversion for atrial fibrillation or flutter. Acad Emerg Med 2010; 17: 408-415.
4. Pisters R, Nieuwlaat R, Prins MH, Le Heuzey JY, Maggioni AP, Camm AJ, Crijns HJ, et al. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: The Euro Heart Survey. Europace 2012; 14: 666-674.
5. Glover BM, Walsh SJ, McCann CJ, Moore MJ, Manoharan G, Dalzell GW, McAllister A, et al. Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. BEST AF Trial Heart 2008; 94: 884-887.
6. Fumagalli S, Boncinelli L, Bondi E, Caleri V, Gatto S, Di Bari M, Baldereschi G, et al. Does advanced age affect the immediate and long-term results of direct-current external cardioversion of atrial fibrillation ? J Am Geriatr Soc 2002; 50: 1192-1197.
7. Frick M, Frykman V, Jensen-Urstad M, Ostergren J, Rosenqvist M,. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. Clin Cardiol 2001; 24: 238-244.
8. Mittal S, Ayati S, Stein KM, Schwartzman D, Cavlovich D, Tchou PJ, Markowitz SM, et al. Transthoracic cardioversion of atrial fibrillation: Comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 2000; 101: 1282-1287.
9. Botto GL, Politi A, Bonini W, Broffoni T, Bonatti R,. External cardioversion of atrial fibrillation: Role of paddle position on technical efficacy and energy requirements. Heart 1999; 82: 726-730.
10. Mathew TP, Moore A, McIntyre M, Harbinson MT, Campbell NP, Adgey AA, Dalzell GW,. Randomised comparison of electrode positions for cardioversion of atrial fibrillation. Heart 1999; 81: 576-579.
11. Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI,. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991; 68: 41-16.
12. Blich M, Edoute Y,. Electrical cardioversion for persistent or chronic atrial fibrillation: Outcome and clinical factors predicting short and long term success rate. Int J Cardiol 2006; 107: 389-394.
13. Kirchhof P, Eckardt L, Loh P, Weber K, Fischer RJ, Seidl KH, Böcker D, et al. Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: A randomised trial. Lancet 2002; 360: 1275-1279.
14. Blecher GE, Stiell IG, Rowe BH, Lang E, Brison RJ, Perry JJ, Clement CM, et al. Use of rate control medication before cardioversion of recent-onset atrial fibrillation or flutter in the emergency department is associated with reduced success rates. CJEM 2012; 14: 169-177.
15. Scheuermeyer FX, Grafstein E, Stenstrom R, Innes G, Heslop C, Macphee J, Pourvali R, et al. Thirty-day and 1-year outcomes of emergency department patients with atrial fibrillation and no acute underlying medical cause. Ann Emerg Med 2012; 60: 755-765.
16. Burton JH, Vinson DR, Drummond K, Strout TD, Thode HC, McInturff JJ,. Electrical cardioversion of emergency department patients with atrial fibrillation. Ann Emerg Med 2004; 44: 20-30.
17. Airaksinen KE, Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Biancari F, Hartikainen JE,. Thromboembolic complications after cardioversion of acute atrial fibrillation: The FinCV (Finnish CardioVersion) study. J Am Coll Cardiol 2013; 62: 1187-1192.
18. Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Vasankari T, Hartikainen JE, Airaksinen KE,. Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: The FinCV study. Europace 2013; 15: 1432-1435.
19. Nuotio I, Hartikainen JE, Grönberg T, Biancari F, Airaksinen KE,. Time to cardioversion for acute atrial fibrillation and thromboembolic complications. JAMA 2014; 312: 647-649.
20. Wasmund SL, Li JM, Page RL, Joglar JA, Kowal RC, Smith ML, Hamdan MH,. Effect of atrial fibrillation and an irregular ventricular response on sympathetic nerve activity in human subjects. Circulation 2003; 107: 2011-2015.
21. Dittrich HC, Erickson JS, Schneiderman T, Blacky AR, Savides T, Nicod PH,. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 1989; 63: 193-197.
22. Crijns HJ, Weijs B, Fairley AM, Lewalter T, Maggioni AP, Martín A, Ponikowski P, et al. Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study. Int J Cardiol 2014; 172: 588-594.
23. Lindberg S, Hansen S, Nielsen T,. Spontaneous conversion of first onset atrial fibrillation. Intern Med J 2012; 42: 1195-1199.
24. Bellone A, Etteri M, Vettorello M, Bonetti C, Clerici D, Gini G, Maino C, et al. Cardioversion of acute atrial fibrillation in the emergency department: A prospective randomised trial. Emerg Med J 2012; 29: 188-191.